These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20627233)

  • 1. [Cowden syndrome, or multiple hamartomatous tumor syndrome, in clinical endocrinology].
    Sardinoux M; Raingeard I; Bessis D; Coupier I; Renard E; Bringer J
    Ann Endocrinol (Paris); 2010 Sep; 71(4):264-73. PubMed ID: 20627233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN hamartoma tumor syndromes.
    Blumenthal GM; Dennis PA
    Eur J Hum Genet; 2008 Nov; 16(11):1289-300. PubMed ID: 18781191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug development.
    Lopiccolo J; Ballas MS; Dennis PA
    Crit Rev Oncol Hematol; 2007 Sep; 63(3):203-14. PubMed ID: 17643312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cowden syndrome: report of two cases with immunohistochemical analysis for PTEN expression.
    Zabetian S; Mehregan D
    Am J Dermatopathol; 2012 Aug; 34(6):632-4. PubMed ID: 22481496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis.
    Yeager N; Klein-Szanto A; Kimura S; Di Cristofano A
    Cancer Res; 2007 Feb; 67(3):959-66. PubMed ID: 17283127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
    Fackenthal JD; Marsh DJ; Richardson AL; Cummings SA; Eng C; Robinson BG; Olopade OI
    J Med Genet; 2001 Mar; 38(3):159-64. PubMed ID: 11238682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing PTEN immunohistochemistry as a screening test for Cowden syndrome.
    Hartsough E; DeSimone MS; Lorenzo ME; Dias-Santagata D; Nose V; Hoang MP
    Am J Clin Pathol; 2024 May; 161(5):490-500. PubMed ID: 38206110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features.
    Pilarski R; Stephens JA; Noss R; Fisher JL; Prior TW
    J Med Genet; 2011 Aug; 48(8):505-12. PubMed ID: 21659347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer.
    Slomovitz BM; Coleman RL
    Clin Cancer Res; 2012 Nov; 18(21):5856-64. PubMed ID: 23082003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome.
    Barletta JA; Bellizzi AM; Hornick JL
    Am J Surg Pathol; 2011 Oct; 35(10):1505-11. PubMed ID: 21921783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cowden syndrome presenting with trichilemmomas.
    Ng E; Terushkin V; Meehan SA; Ho R; Pomeranz MK
    Dermatol Online J; 2016 Dec; 22(12):. PubMed ID: 28329541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hamartoma-like lesions in the mouse retina: an animal model of
    Tachibana N; Touahri Y; Dixit R; David LA; Adnani L; Cantrup R; Aavani T; Wong RO; Logan C; Kurek KC; Schuurmans C
    Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29716894
    [No Abstract]   [Full Text] [Related]  

  • 13. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
    He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
    Pilarski R; Burt R; Kohlman W; Pho L; Shannon KM; Swisher E
    J Natl Cancer Inst; 2013 Nov; 105(21):1607-16. PubMed ID: 24136893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
    Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
    J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes.
    Orloff MS; He X; Peterson C; Chen F; Chen JL; Mester JL; Eng C
    Am J Hum Genet; 2013 Jan; 92(1):76-80. PubMed ID: 23246288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatase and tensin homolog immunohistochemical staining and clinical criteria for Cowden syndrome in patients with trichilemmoma or associated lesions.
    Jin M; Hampel H; Pilarski R; Zhou X; Peters S; Frankel WL
    Am J Dermatopathol; 2013 Aug; 35(6):637-40. PubMed ID: 23715080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
    Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
    Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic and Therapeutic Targeting of PTEN Loss in Bone Malignancies.
    Xi Y; Chen Y
    J Cell Biochem; 2015 Sep; 116(9):1837-47. PubMed ID: 25773992
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.